{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:41:57Z","timestamp":1792708917382,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"vor","delay-in-days":368,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuron.2016.03.016","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T23:56:10Z","timestamp":1460678170000},"page":"507-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington\u2019s Disease-Associated Phenotypes In\u00a0Vivo"],"prefix":"10.1016","volume":"90","author":[{"given":"Joseph","family":"Ochaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex\u00a0Mas","family":"Monteys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline\u00a0G.","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack\u00a0C.","family":"Reidling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan\u00a0S.","family":"Steffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly\u00a0L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie\u00a0M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2016.03.016_bib1","doi-asserted-by":"publisher","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2016.03.016_bib2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2016.03.016_bib3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-kappa B as a therapeutic target in neurodegenerative diseases","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuron.2016.03.016_bib4","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuron.2016.03.016_bib7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/brain\/awt061","article-title":"Interferon \u03b2 induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice","volume":"136","author":"Chort","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2016.03.016_bib8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbr.2015.05.010","article-title":"Progression of behavioural despair in R6\/2 and Hdh knock-in mouse models recapitulates depression in Huntington\u2019s disease","volume":"291","author":"Ciamei","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2016.03.016_bib9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.devcel.2012.11.020","article-title":"SUMO: a multifaceted modifier of chromatin structure and function","volume":"24","author":"Cube\u00f1as-Potts","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib11","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/jcbfm.2011.112","article-title":"SUMO2\/3 conjugation is an endogenous neuroprotective mechanism","volume":"31","author":"Datwyler","year":"2011","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuron.2016.03.016_bib12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuron.2016.03.016_bib13","doi-asserted-by":"publisher","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.neuron.2016.03.016_bib14","doi-asserted-by":"publisher","first-page":"456857","DOI":"10.1155\/2013\/456857","article-title":"Bidirectional microglia-neuron communication in the healthy brain","volume":"2013","author":"Eyo","year":"2013","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuron.2016.03.016_bib15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrm3011","article-title":"The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition","volume":"11","author":"Gareau","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuron.2016.03.016_bib16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/BF00294227","article-title":"Synaptophysin expression in the striatum in Huntington\u2019s disease","volume":"80","author":"Goto","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2016.03.016_bib17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2016.03.016_bib18","doi-asserted-by":"publisher","first-page":"e9805","DOI":"10.1371\/journal.pone.0009805","article-title":"Loss of ALS2\/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking","volume":"5","author":"Hadano","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2016.03.016_bib19","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2016.03.016_bib20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2016.03.016_bib21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2016.03.016_bib22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuron.2016.03.016_bib23","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington\u2019s disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2016.03.016_bib24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2016.03.016_bib25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5607\/en.2013.22.2.59","article-title":"Brain inflammation and microglia: facts and misconceptions","volume":"22","author":"Jeong","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neuron.2016.03.016_bib26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2011.04.015","article-title":"The role of I\u03baB kinase complex in the neurobiology of Huntington\u2019s disease","volume":"43","author":"Khoshnan","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2016.03.016_bib27","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00018-012-1158-3","article-title":"Sumoylation in neurodegenerative diseases","volume":"70","author":"Krumova","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrg2748","article-title":"Repeat expansion disease: progress and puzzles in disease pathogenesis","volume":"11","author":"La Spada","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuron.2016.03.016_bib29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.12.008","article-title":"The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington\u2019s disease and in striatal tissue from Huntington\u2019s disease patients","volume":"267","author":"Laprairie","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuron.2016.03.016_bib30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.molcel.2009.07.021","article-title":"Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes","volume":"35","author":"Lee","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2016.03.016_bib32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tips.2008.07.008","article-title":"Targeting the PIAS1 SUMO ligase pathway to control inflammation","volume":"29","author":"Liu","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2009.09.002","article-title":"Summon SUMO to wrestle with inflammation","volume":"35","author":"Liu","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/ni1104","article-title":"PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity","volume":"5","author":"Liu","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuron.2016.03.016_bib35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/MCB.25.3.1113-1123.2005","article-title":"Negative regulation of NF-kappaB signaling by PIAS1","volume":"25","author":"Liu","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuron.2016.03.016_bib36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cell.2007.03.056","article-title":"Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity","volume":"129","author":"Liu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib37","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1128\/MCB.00723-13","article-title":"Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT\/enhancer-binding protein \u03b2 (C\/EBP\u03b2) during adipogenesis","volume":"33","author":"Liu","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuron.2016.03.016_bib38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nn.3367","article-title":"Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance","volume":"16","author":"Lu","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib40","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","article-title":"The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus","volume":"19","author":"Marcora","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2016.03.016_bib41","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2016.03.016_bib42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation","volume":"4","author":"O\u2019Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2016.03.016_bib43","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuron.2016.03.016_bib44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib45","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","article-title":"Astrocyte reactivity and reactive astrogliosis: costs and benefits","volume":"94","author":"Pekny","year":"2014","journal-title":"Physiol. Rev."},{"issue":"R1","key":"10.1016\/j.neuron.2016.03.016_bib46","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1093\/hmg\/ddn412","article-title":"Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity","volume":"18","author":"Pennuto","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2016.03.016_bib47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/biom5020617","article-title":"Posttranslational Modifications and Clearing of \u03b1-Synuclein Aggregates in Yeast","volume":"5","author":"Popova","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuron.2016.03.016_bib48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tibs.2011.09.002","article-title":"SUMO playing tag with ubiquitin","volume":"37","author":"Praefcke","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib49","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/brain\/awm219","article-title":"Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis","volume":"130","author":"Rasmussen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2016.03.016_bib50","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1242\/jcs.03243","article-title":"Multiple domains in Siz SUMO ligases contribute to substrate selectivity","volume":"119","author":"Reindle","year":"2006","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuron.2016.03.016_bib52","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00018-009-0061-z","article-title":"PIAS proteins: pleiotropic interactors associated with SUMO","volume":"66","author":"Rytinki","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2009.01.004","article-title":"Sumoylation and human disease pathogenesis","volume":"34","author":"Sarge","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tins.2010.07.004","article-title":"Protein modifications involved in neurotransmitter and gasotransmitter signaling","volume":"33","author":"Sen","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2016.03.016_bib55","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","volume":"16 Spec No. 2","author":"Shao","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2016.03.016_bib56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.cr.7310027","article-title":"Regulation of cytokine signaling pathways by PIAS proteins","volume":"16","author":"Shuai","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.neuron.2016.03.016_bib57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nri1667","article-title":"Regulation of gene-activation pathways by PIAS proteins in the immune system","volume":"5","author":"Shuai","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuron.2016.03.016_bib58","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuron.2016.03.016_bib59","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuron.2016.03.016_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JHD-2012-129004","article-title":"Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small Molecules","volume":"1","author":"Sontag","year":"2012","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.neuron.2016.03.016_bib61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuron.2016.03.016_bib62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington\u2019s disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuron.2016.03.016_bib63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1389203711314010004","article-title":"Neuron-microglia interaction in neuroinflammation","volume":"14","author":"Suzumura","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.neuron.2016.03.016_bib64","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib65","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuron.2016.03.016_bib66","doi-asserted-by":"publisher","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2016.03.016_bib67","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"Waelter","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuron.2016.03.016_bib68","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2016.03.016_bib69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.brainresrev.2010.04.002","article-title":"Targets and consequences of protein SUMOylation in neurons","volume":"64","author":"Wilkinson","year":"2010","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuron.2016.03.016_bib70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627316300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627316300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:25:33Z","timestamp":1600453533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627316300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0896627316300058"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2016.03.016","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington\u2019s Disease-Associated Phenotypes In\u00a0Vivo","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2016.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}